The Food and Drug Administration has recently revised portions of Section 6 of its Regulatory Procedures Manual, which, among other things, outlines internal agency procedures regarding Park Doctrine prosecutions. After years of dormancy, these procedures reflect the agency’s renewed interest in using the longstanding Park doctrine as part of its enforcement regime. After providing some background information, this memorandum summarizes FDA’s current approach to Park prosecutions.
Click here to read more